Electromed, Inc.
AMEX:ELMDMedical - Devices
+$0.43 today
- Market cap
- $191.27M
- Beta
- 0.52
- P/E (TTM)
- 30.5
- EPS (TTM)
- $1.23
Volume 0.05M
Average 0.06M
ELMD Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Electromed, Inc.AMEX: ELMD
Cash & Equivalents · Q3 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 11.5% from a year ago
Cash & equivalents stood at $16.99M at the end of Q3 FY2026, up 11.5% from a year earlier and up 23.2% from the prior quarter. Over 3 fiscal years it compounded at +23.3% a year.
Context
- Cash & equivalents amounted to 28.6% of total assets at the end of Q3 FY2026, down 0.5 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +11.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 15.29M USD
- Year-over-year change
- -4.9%
- 4-year CAGR
- +6.5%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 15.29M | -4.9% |
| FY2024 | 2024-06-30 | 16.08M | +118.1% |
| FY2023 | 2023-06-30 | 7.37M | -9.6% |
| FY2022 | 2022-06-30 | 8.15M | -31.4% |
| FY2021 | 2021-06-30 | 11.89M | — |
Cash & Equivalents vs competitors
How ELMD compares with its peers on the latest reported figures
- ELMD's Mar 2026 cash & equivalents of $16.99M is the 5th highest of the 6 companies compared; the peer median is $61.57M.
- Its year-over-year change of +11.5% is the 2nd highest of 6, against a peer median of -10.3%.
- Cash & equivalents amounts to 28.6% of total assets for ELMD, versus a peer median of 16.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.47B | +21.5% | +86.1% | 16.4% | |
| Mar 2026 | $74.99M | -10.3% | +56.1% | 27.6% | |
| Mar 2026 | $61.57M | -17.4% | -11.7% | 51.3% | |
| Apr 2026 | $47.96M | -10.6% | +31.9% | 1.1% | |
| Mar 2026 | $16.99M | +11.5% | +23.3% | 28.6% | |
| Mar 2026 | $9.76M | -3.9% | -7.2% | 4.9% | |
| Peer median (excluding ELMD) | $61.57M | -10.3% | +31.9% | 16.4% | |
Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 11.89M | 8.15M | 7.37M | 16.08M | 15.29M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 17.43M | 21.34M | 24.62M | 24.05M | 25.7M |
| Inventory | 2.11M | 3.18M | 4.22M | 3.71M | 3.3M |
| Other Current Assets | 276K | 1.87M | 1.58M | 1 | 408K |
| Total Current Assets | 31.7M | 34.54M | 37.79M | 44.17M | 45.08M |
| Property, Plant & Equipment (Net) | 3.69M | 4.69M | 5.67M | 5.25M | 4.91M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 663K | 599K | 605K | 657K | 1.32M |
| Long-term Investments | (88K) | (120M) | 0 | 0 | 0 |
| Tax Assets | 1.05M | 1.54M | 1.58M | 0 | 0 |
| Other Non-current Assets | 88K | 120M | 161K | 2.15M | 2.49M |
| Total Non-current Assets | 5.41M | 6.83M | 8.02M | 8.06M | 8.72M |
| Total Assets | 37.11M | 41.36M | 45.81M | 52.23M | 53.8M |
| Account Payables | 685K | 1.26M | 1.37M | 1.01M | 2.67M |
| Short-term Debt | 33K | 0 | 80K | 0 | 0 |
| Tax Payables | 288K | 51K | 336K | 0 | 0 |
| Deferred Revenue | 0 | 1.54M | (80K) | 0 | 0 |
| Other Current Liabilities | 940K | (203K) | 1.45M | 1.84M | 1.65M |
| Total Current Liabilities | 4.64M | 7.15M | 8.05M | 7.68M | 10.47M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 5K | 0 | 0 |
| Total Non-current Liabilities | 54K | 41K | 86K | 12K | 125K |
| Total Liabilities | 4.69M | 7.19M | 8.14M | 7.69M | 10.59M |
| Common Stock | 85K | 85K | 86K | 87K | 83K |
| Retained Earnings | 14.92M | 15.78M | 18.79M | 23.67M | 21.19M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | (0) |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 32.42M | 34.17M | 37.67M | 44.55M | 43.21M |
| Total Debt | 87K | 41K | 161K | 87K | 198K |
| Net Debt | (11.8M) | (8.11M) | (7.21M) | (15.99M) | (15.09M) |
Electromed, Inc.
AMEX:ELMD
Intrinsic Alpha fair value
Locked
Current Price
$23.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.